Another lawmaker is taking on a pharmaceutical company for drug pricing. Source: BioSpace

AbbVie's investigational JAK1-inhibitor upadacitinib yielded positive top-line results in a Phase III trial as a monotherapy for rheumatoid arthritis patients. Source: BioSpace

Millendo Therapeutics announced that it has acquired Alize Pharma SAS in a stock-based transaction. Source: BioSpace

The parent company of JSR Life Sciences snapped up CRO Crown Bioscience International for $400M, the company announced this morning. Source: BioSpace

Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 magnetic beads as part of the clinical and commercial manufacturing processes for its…

Baillie Gifford and ORI Capital co-led the financing with significant new investments from Temasek and Cowen Healthcare Investments, alongside Juda Capital, Pavilion Capital, RTW Investments, Agent Capital, 4BIO Capital and…

A little less than two years after tying up a multi-billion deal with Sanofi, DiCE Molecules scored another collaborative deal. Source: BioSpace

Should you invest the way billionaire investors do? Source: BioSpace

The fact that Roche has separate R&D units has been the topic of second-guessing on the part of observers and analysts. Source: BioSpace

Array BioPharma announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations. Source: BioSpace